News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Point Therapeutics Announces Time Change For January 31, 2006 Webcast; Webcast On Phase 3 NSCLC Program And Clinical Update Moved To 8:30 AM EST
January 26, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOSTON--(BUSINESS WIRE)--Jan. 26, 2006--Point Therapeutics, Inc. (NASDAQ:POTP) announced today that it has changed the start time for its live webcast on Tuesday, January 31 to 8:30 AM EST. The webcast may be accessed by visiting www.pther.com.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
MORE ON THIS TOPIC
Cardiovascular disease
BMS Jettisons Coronary Trial for J&J-Partnered Anticoagulant
November 14, 2025
·
1 min read
·
Dan Samorodnitsky
HIV
Gilead Looks To Simplify HIV Treatment By Combining Two Leading Drugs in One Pill
November 14, 2025
·
2 min read
·
Tristan Manalac
RNA editing
Korro Suffers Cacophony of Bad News as Lead Candidate Fails, Novo Pauses RNA Deal
November 13, 2025
·
3 min read
·
Annalee Armstrong
Obesity
Zealand Freezes Mid-Stage Obesity Asset To Focus on More Differentiated Drugs
November 13, 2025
·
2 min read
·
Tristan Manalac